Investor Relations

Organigram is a leading Canadian licensed producer of high-quality medical and recreational cannabis.

NASDAQ (OGI) TSX (OGI)

Organigram Announces C$124.6 Million Investment from BAT and Creation of “Jupiter” Strategic Investment Pool

Investor Presentations

View Presentations

Our Facility

Press Releases

September 3rd, 2024

Organigram Closes Second Tranche of Previously Announced BAT Private Placement Investment

August 13th, 2024

Organigram Reports Third Quarter Fiscal 2024 Results

August 7th, 2024

Organigram Product Development Collaboration Completes Landmark Clinical Study on Nanoemulsion Technology

All Press Releases

Investor Events

August 13th, 2024

Organigram Reports Third Quarter Fiscal 2024 Results

Call Replay Press Release Presentation Transcript

May 14th, 2024

Organigram Reports Second Quarter Fiscal 2024 Results

Call Replay Press Release Presentation Transcript

February 13th, 2024

Organigram First Quarter Fiscal 2024 Results

Call Replay Press Release Presentation Transcript